Evidence map›Paper›PMID 33870721›Full record

ArticlePhysiological genomics2021

Sexual dimorphism in the progression of type 2 diabetic kidney disease in T2DN rats.

Denisha R Spires, Oleg Palygin, Vladislav Levchenko, Elena Isaeva, Christine A Klemens, Sherif Khedr, Oksana Nikolaienko, Alison Kriegel, Xi Cheng, Ji-Youn Yeo and 2 more

Open access · greenAbstract read
In one paragraph

Article in Physiological genomics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. SGLT2 inhibition effect on salt-induced hypertension, RAAS, and NaAmerican journal of physiology. Renal physiology · 2022
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Denisha R SpiresDepartment of Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin.
Oleg PalyginDepartment of Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin.ORCID 0000-0002-3680-5527
Vladislav LevchenkoDepartment of Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin.
Elena IsaevaDepartment of Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin.ORCID 0000-0002-0587-6322
Christine A KlemensDepartment of Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin.ORCID 0000-0002-0812-824X
Sherif KhedrDepartment of Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin.
Oksana NikolaienkoDepartment of Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin.
Alison KriegelDepartment of Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin.
Xi ChengDepartment of Physiology and Pharmacology, University of Toledo, Ohio.ORCID 0000-0002-0838-5094
Ji-Youn YeoDepartment of Physiology and Pharmacology, University of Toledo, Ohio.
Bina JoeDepartment of Physiology and Pharmacology, University of Toledo, Ohio.
Alexander StaruschenkoDepartment of Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin.ORCID 0000-0002-5190-8356
Medical College of Wisconsin · USUniversity of Toledo · USAin Shams University · EG

Funding

Coordinating and Bioinformatics Unit for the MMPC/DiaCompU24DK076169 · NIDDK · AUGUSTA UNIVERSITY · PI MCINDOE, RICHARD A. · 2006 to 2018
$42.4M
ZONISMIDE IN THE TREATMENT OF SEIZURES IN PATIENTSM01RR000058 · NCRR · MEDICAL COLLEGE OF WISCONSIN · PI BROUSSEAU, DAVID C · 1985 to 2006
$19.9M
Therapeutic Effects of mTOR Inhibition in Salt-Sensitive HypertensionP01HL116264 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI MATTSON, DAVID L. · 2013 to 2021
$18.7M
Coordinating Unit for DiaCompU24DK115255 · NIDDK · AUGUSTA UNIVERSITY · PI MCINDOE, RICHARD A. · 2017 to 2020
$11.6M
Training in Signature Transdisciplinary Cardiovascular SciencesT32HL134643 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI Justin L Grobe, Jacquelyn P Kulinski · 2017 to 2026
$4.2M
Renal ion channels in the control of blood pressureR35HL135749 · NHLBI · UNIVERSITY OF SOUTH FLORIDA · PI STARUSCHENKO, ALEXANDER · 2017 to 2023
$3.6M
Genetic, Epigenetic and Dietary Salt effects on Microbiota and HypertensionR01HL143082 · NHLBI · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI JOE, BINA · 2018 to 2021
$2.6M
Role of basolateral K channels in renal salt handling and BP controlR01DK126720 · NIDDK · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI PALYGIN, OLEG · 2021 to 2024
$1.5M
Transport and metabolism in the kidneyI01BX004024 · VA · JAMES A. HALEY VA MEDICAL CENTER · PI STARUSCHENKO, ALEXANDER · 2019 to 2025
–
BLRD VA I01 BX004024NCRR NIH HHS M01 RR000058NHLBI NIH HHS P01 HL116264NHLBI NIH HHS R01 HL143082NHLBI NIH HHS R35 HL135749NHLBI NIH HHS T32 HL134643NIDDK NIH HHS R01 DK126720NIDDK NIH HHS U24 DK076169NIDDK NIH HHS U24 DK115255
6 · The paper itself

Abstract

Diabetic kidney disease (DKD) is a common complication of diabetes, which frequently leads to end-stage renal failure and increases cardiovascular disease risk. Hyperglycemia promotes renal pathologies such as glomerulosclerosis, tubular hypertrophy, microalbuminuria, and a decline in glomerular filtration rate. Importantly, recent clinical data have demonstrated distinct sexual dimorphism in the pathogenesis of DKD in people with diabetes, which impacts both severity- and age-related risk factors. This study aimed to define sexual dimorphism and renal function in a nonobese type 2 diabetes model with the spontaneous development of advanced diabetic nephropathy (T2DN rats). T2DN rats at 12- and over 48-wk old were used to define disease progression and kidney injury development. We found impaired glucose tolerance and glomerular hyperfiltration in T2DN rats to compare with nondiabetic Wistar control. The T2DN rat displays a significant sexual dimorphism in insulin resistance, plasma cholesterol, renal and glomerular injury, urinary nephrin shedding, and albumin handling. Our results indicate that both male and female T2DN rats developed nonobese type 2 DKD phenotype, where the females had significant protection from the development of severe forms of DKD. Our findings provide further evidence for the T2DN rat strain's effectiveness for studying the multiple facets of DKD.

Indexed as

AlbuminuriaAnimalsBiomarkersBlood GlucoseDiabetes Mellitus, Type 2Diabetic NephropathiesDisease ProgressionElectrolytesFemaleGlomerular Filtration RateGlucose Tolerance TestHumansInsulin ResistanceKidneyMaleMetabolomicsBiomarkersBlood GlucoseElectrolytesdiabetic kidney diseasediabetic nephropathynonobesesex differences

Identifiers

PMID33870721
PMCPMC8285576
OpenAlexW3154982802

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.